Phytomedicine
Volume 14, Issue 4 , Pages 273-279, 10 April 2007

Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): Lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development☆

  • K.M. Wu

      Affiliations

    • Center for Drug Evaluation and Research, FDA, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • J.G. Farrelly

      Affiliations

    • Center for Drug Evaluation and Research, FDA, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
    • ,
  • R. Upton

      Affiliations

    • American Herbal Pharmacopoeia, Scotts Valley, CA 95067, USA
    • ,
  • J. Chen

      Affiliations

    • Chengdu University of TCM, Chengdu, Sichuan, PR China

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ A preliminary report of this article has been presented at the FDA Science Forum in Washington, DC, 2005 and Annual Meeting of American Society of Pharmacognosy at Corvallis, Oregon, 2005. This article is not an official FDA guidance or policy statement. No official endorsement by the FDA is intended.

PII: S0944-7113(06)00099-7

doi:10.1016/j.phymed.2006.05.009

Phytomedicine
Volume 14, Issue 4 , Pages 273-279, 10 April 2007

Article Tools